Concepedia

Publication | Open Access

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

DOIFull Paper Access

141

Citations

41

References

2020

Year

Ana C. Garrido-Castro, Cristina Saura, Romualdo Barroso‐Sousa, Hao Guo, Eva Ciruelos, Begoña Bermejo, Joaquín Gavilá, Violeta Serra, Aleix Prat, Laia Paré,
Breast Cancer Research

References

YearCitations

Page 1